David T. Beattie

AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity

Jacqueline H. L. Fok, Antonio Ramos‐Montoya, Mercedes Vázquez–Chantada et al. · Nature Communications · 2019 · 334 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis

Charles W. Rittershaus, David P. Miller, Lawrence J. Thomas et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 312 citations

Life Sciences, Biochemistry, Immunology +16

Identification of novel staphylococcal virulence genes by<i>in vivo</i>expression technology

Adrian M. Lowe, David T. Beattie, Robert L. Deresiewicz · Molecular Microbiology · 1998 · 191 citations · Full text

Life Sciences, Genetics, Microbiology +17

Use of genetic recombination as a reporter of gene expression.

Andrew Camilli, David T. Beattie, John J. Mekalanos · Proceedings of the National Academy of Sciences · 1994 · 171 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Synthesis and antifungal activity of 3-(1,3,4-oxadiazol-5-yl)-indoles and 3-(1,3,4-oxadiazol-5-yl)methyl-indoles

Ming‐Zhi Zhang, Nick Mulholland, David T. Beattie et al. · European Journal of Medicinal Chemistry · 2013 · 152 citations

Pharmacy, Chemistry, Medicinal Chemistry +10